Bank Of Montreal Nurix Therapeutics, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$4.25 - $10.71 $116,450 - $293,454	27,400 New	27,400 $282,000
Q2 2022 Aug 11, 2022	BUY	$7.88 - $14.82 $189,939 - $357,221	24,104 New	24,104 $289,000
Q4 2021 Feb 11, 2022	SELL	$26.43 - $34.5 $4.34 Million - $5.67 Million	-164,255 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$22.71 - $36.69 $3.73 Million - $6.03 Million	164,255 New	164,255 $5.37 Million

181

68.1M

78K

53.8K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $1.03B
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.